Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Inactivated Vaccines Industry By 2029?

The market capacity of inactivated vaccines has been on a consistent growth trajectory in the past few years. Rising from $6.19 billion in 2024, it is expected to reach $6.37 billion in 2025. This signifies a compound annual growth rate (CAGR) of 2.8%. The growth observed in the historic period is resultant from efforts towards the eradication of polio, initiation of flu vaccination schemes, emergence of new infectious diseases and regulatory authorizations.

The market for inactivated vaccines is projected to experience consistent expansion in the coming years. It’s estimated to reach a value of “$7.58 billion by 2029,” progressing at a compound annual growth rate (CAGR) of 4.5%. This growth in the predicted timeframe can be linked to the preparedness for pandemics, increased vaccine coverage, advancements in biomanufacturing, and initiatives toward health equity. Key trends during this forecast period consist of mRNA vaccine platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

What Underlying Factors Are Supporting The Inactivated Vaccines Market Growth?

The climbing rate of infectious diseases is projected to boost the expansion of the inactivated vaccine market. Pathogens like bacteria, viruses, fungi, or parasites cause infectious diseases that can be transmitted from one person to another, leading to diverse symptoms and health problems. An example of such a disease is Tuberculosis. Using inactivated or non-living pathogens, vaccines stimulate an immune response, efficiently thwarting diseases such as polio, hepatitis A, and influenza. A report by the Centers for the Disease Control and Prevention, a national public health agency in the US, noted in November 2023 that Tuberculosis cases in the US rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. This surge in infectious disease prevalence thus fuels the growth of the inactivated vaccine market.

What Is The Segment Breakdown Of The Inactivated Vaccines Market?

The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

How Are Global Trends Impacting The Development Of The Inactivated Vaccines Market?

Leading firms in the inactivated vaccines market are developing and introducing new and improved inactivated vaccines to maintain their market dominance. Inactivated vaccines are made up of inactivated or killed virus particles, bacteria, or other pathogens which were grown in a culture. For example, in January 2022, GSK PLC, a pharmaceutical and biotechnology company headquartered in the UK, launched a new inactivated vaccine, Shingrix, aimed at helping to protect against shingles (Herpes zoster). Shingrix, a non-live, recombinant subunit adjuvanted vaccine, is given via two intramuscular injections. Initially, the vaccine was indicated for people aged 50 and above. However, its use has since been broadened to include those aged 18 and above who are at an increased risk of developing shingles due to immunodeficiency or immunosuppression arising from an identified disease or treatment.

Who Are The Leading Companies Driving The Inactivated Vaccines Market?

Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Which Region Is Leading Innovation In The Inactivated Vaccines Market?

North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model